Clinical Trial for Contraceptive Efficacy
Northwest Clinical Research Center is conducting a contraceptive efficacy study for women diagnosed with uterine fibroids and/or endometriosis. This drug combines three already FDA approved medications that are individually used for either contraception or control of heavy bleeding from fibroids. We are testing the combination for efficacy as an oral contraceptive.
Prerequisites
Potential participants must be:
- Premenopausal Women Aged 18 to 50 years of age
- At risk of pregnancy, with normal, regular menstrual cycles
- Has a Diagnosis of Uterine Fibroids or Endometriosis
No Cost Study
There is no cost to participate in this clinical study. The participant, if they qualify, will receive:
- Medical Evaluation
- Investigational medication
- Study related medical care
- Compensation available
In addition, study related travel compensation or complimentary transportation may be available